Company: TVRD
Filing Date: 2025-01-27
Form Type: S-4/A
Source: 0001104659-25-006050
Chunk: 583

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-01-27
Form: S-4/A
Chunk 583
---
    |       ​ 
       ​ 
       ​ | ​ 
 ​ 
 ​ 
 ​ | ​      
 ​      
 ​      
 Change 
 Amount 
 ​      |      ​ 
      ​ 
      ​ 
      ​ | ​ 
 ​ 
 ​ |       ​ 
       ​ 
       ​ 
 Percent 
       ​ | ​ 
 ​ 
 ​ 
 ​ 
 ​ |
|:---------------------------|:--|:------------------|--------:|:--|:-----|--------:|:--|:-------|-------:|:--|--------:|:--|
| Research and development   | ​ | $                 |  15,047 | ​ | $    |  11,884 | ​ | $      |  3,163 |   |    26.6 | % |
| General and administrative | ​ |                   |   2,258 | ​ |      |   2,117 | ​ |        |    141 |   |     6.7 | % |
| Total operating expenses   | ​ |                   |  17,305 | ​ |      |  14,001 | ​ |        |  3,304 |   |    23.6 | % |
| Loss from operations       | ​ |                   | -17,305 | ​ |      | -14,001 | ​ |        | -3,304 |   |    23.6 | % |
| Interest income            | ​ |                   |     615 | ​ |      |   1,005 | ​ |        |   -390 |   |   -38.8 | % |
| Net loss                   | ​ | $                 | -16,690 | ​ | $    | -12,996 | ​ | $      | -3,694 |   |    28.4 | % |

319

Research and Development Expenses Research and development expenses for the nine months ended September 30, 2024 and 2023 were comprised of the following (in thousands, except percentages):

| ​                                                    
 ​                                                    
 ​                                                    
 ​                                                    
 Direct research and development expenses by program: 
 TTI-101:                                             | ​ 
 ​ 
 ​ 
 ​ 
 ​ | ​                 
 Nine Months Ended 
 September 30,     
 2024              
 ​                 
 ​                 |      ​ 
      ​ 
      ​ | ​ 
 ​ 
 ​ | ​    
 2023 
 ​    
 ​    |      ​ 
      ​